We have located links that may give you full text access.
A clinical review of the IOLAB Azar model 91Z flexible anterior chamber intraocular lens.
Ophthalmic Surgery 1987 April
The IOLAB AZAR 91Z flexible anterior chamber intraocular lens may have the highest complication rate of any contemporary intraocular implant. Over 40,000 of these implants were inserted in human eyes. The complications of this lens includes a much higher than normal rate of chronic inflammation, cystoid macular edema, glaucoma, hyphema, vitreous hemorrhage, and pseudophakic bullous keratopathy. These complications together constitute the multiple manifestations of the UGH Plus syndrome. These complications tend to increase with time. The failure of the 91Z can be ascribed to problems of design and manufacturing causing excess movement, vaulting, and irritation of ocular tissue. Patients with this implant need to be notified of the high complication rate and the need for frequent follow-up. Most 91Z complications are recurrent or persistent and respond best to removal of the implant. Removal of the 91Z requires special technique to avoid traumatizing the eye. The design, materials, testing, manufacture, and recall of the 91Z needs close study to prevent another such problem prone lens from reaching widespread use.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app